CAR-T Cell Therapy and Cell-Based Treatments

CAR-T Cell Therapy and Cell-Based Treatments are innovative cancer treatments that involve modifying a patient’s own immune cells to recognize and attack cancer cells. CAR-T (Chimeric Antigen Receptor T-cell) therapy involves collecting T-cells from the patient’s blood, genetically altering them to express a receptor that targets cancer cells, and then re-infusing them into the patient. This enables the T-cells to specifically seek out and destroy cancer cells. Cell-based treatments may also include other immune cells, like natural killer (NK) cells or dendritic cells, which are enhanced or engineered to target and kill cancer cells more effectively. These therapies have shown significant success, particularly in treating certain blood cancers like leukemia and lymphoma, and are being expanded for use in solid tumors.

    Related Conference of CAR-T Cell Therapy and Cell-Based Treatments

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    CAR-T Cell Therapy and Cell-Based Treatments Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in